PMC:7461420 / 70815-71049 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T337","span":{"begin":61,"end":65},"obj":"Disease"},{"id":"T338","span":{"begin":197,"end":201},"obj":"Disease"}],"attributes":[{"id":"A337","pred":"mondo_id","subj":"T337","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A338","pred":"mondo_id","subj":"T338","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"The same group of researchers discovered potent, noncovalent SARS‐CoV‐1 Mpro blockers based on a benzotriazole scaffold in an MLPCN screening, 186 resulting in hit compound 129 (Figure 32) with a SARS‐CoV‐1 Mpro IC50 value of 6.2 µM."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T854","span":{"begin":95,"end":96},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T855","span":{"begin":195,"end":196},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"The same group of researchers discovered potent, noncovalent SARS‐CoV‐1 Mpro blockers based on a benzotriazole scaffold in an MLPCN screening, 186 resulting in hit compound 129 (Figure 32) with a SARS‐CoV‐1 Mpro IC50 value of 6.2 µM."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T91954","span":{"begin":9,"end":14},"obj":"Chemical"},{"id":"T60925","span":{"begin":97,"end":110},"obj":"Chemical"}],"attributes":[{"id":"A72404","pred":"chebi_id","subj":"T91954","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A56282","pred":"chebi_id","subj":"T60925","obj":"http://purl.obolibrary.org/obo/CHEBI_75331"}],"text":"The same group of researchers discovered potent, noncovalent SARS‐CoV‐1 Mpro blockers based on a benzotriazole scaffold in an MLPCN screening, 186 resulting in hit compound 129 (Figure 32) with a SARS‐CoV‐1 Mpro IC50 value of 6.2 µM."}

{"project":"LitCovid-PubTator","denotations":[{"id":"2221","span":{"begin":72,"end":76},"obj":"Gene"},{"id":"2222","span":{"begin":208,"end":212},"obj":"Gene"},{"id":"2223","span":{"begin":61,"end":69},"obj":"Species"},{"id":"2224","span":{"begin":197,"end":205},"obj":"Species"},{"id":"2225","span":{"begin":97,"end":110},"obj":"Chemical"}],"attributes":[{"id":"A2221","pred":"tao:has_database_id","subj":"2221","obj":"Gene:8673700"},{"id":"A2222","pred":"tao:has_database_id","subj":"2222","obj":"Gene:8673700"},{"id":"A2223","pred":"tao:has_database_id","subj":"2223","obj":"Tax:694009"},{"id":"A2224","pred":"tao:has_database_id","subj":"2224","obj":"Tax:694009"},{"id":"A2225","pred":"tao:has_database_id","subj":"2225","obj":"MESH:C012771"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The same group of researchers discovered potent, noncovalent SARS‐CoV‐1 Mpro blockers based on a benzotriazole scaffold in an MLPCN screening, 186 resulting in hit compound 129 (Figure 32) with a SARS‐CoV‐1 Mpro IC50 value of 6.2 µM."}

{"project":"LitCovid-sentences","denotations":[{"id":"T612","span":{"begin":0,"end":234},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The same group of researchers discovered potent, noncovalent SARS‐CoV‐1 Mpro blockers based on a benzotriazole scaffold in an MLPCN screening, 186 resulting in hit compound 129 (Figure 32) with a SARS‐CoV‐1 Mpro IC50 value of 6.2 µM."}